StockWatch
·
HomeLiveWeekly

AIM ImmunoTech Inc.

Ticker: 946644

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-10.22-3.283.6610.60Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026
PeriodQ1 FY2026Q3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024Q3 FY2023
INCOME
Revenue0.02-33.3%0.03+0.0%0.03+50.0%0.02-50.0%0.04-20.0%0.05+25.0%0.04-20.0%0.05
Total Income0.02-33.3%0.03+0.0%0.03+50.0%0.02-50.0%0.04-20.0%0.05+25.0%0.04-20.0%0.05
EXPENSES
Expenditure2.25-8.9%2.47-7.5%2.67-26.6%3.64-19.5%4.52+20.9%3.74-35.2%5.77-29.6%8.20
PROFIT
Net Profit-3.02+7.9%-3.28-17.6%-2.79+24.8%-3.71-0.3%-3.70-101.1%-1.84+68.4%-5.82+25.6%-7.82
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.69-143.9%1.57+142.7%-3.68-7260.0%-0.05+16.7%-0.06-100.0%-0.03+75.0%-0.12+25.0%-0.16

Corporate Events

Board MeetingAIM
2026
15Jul

Board Meeting

Shareholder vote on multiple proposals including the approva…

SEC Filing ↗